Zhejiang Orient Gene Biotech Co., Ltd.
SSE:688298.SS
26.98 (CNY) • At close June 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 3,081.497 | 4,164.736 | 6,596.975 | 6,098.182 | 2,038.613 | 85.437 | 102.551 | 77.907 | 80.787 |
| Short Term Investments
| 207.578 | 1,052.299 | 1,160.676 | 168.068 | 199 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 3,289.075 | 5,217.034 | 7,757.651 | 6,266.25 | 2,237.613 | 85.437 | 102.551 | 77.907 | 80.787 |
| Net Receivables
| 249.282 | 228.438 | 309.357 | 1,184.43 | 625.82 | 83.022 | 58.239 | 47.113 | 38.88 |
| Inventory
| 308.961 | 346.775 | 431.919 | 470.562 | 381.578 | 77.964 | 75.534 | 49.382 | 45.202 |
| Other Current Assets
| 131.447 | 104.01 | 248.554 | 205.182 | 74.329 | 13.265 | 7.395 | 5.331 | 3.981 |
| Total Current Assets
| 3,978.765 | 5,896.257 | 8,747.481 | 8,126.424 | 3,319.339 | 259.687 | 243.718 | 179.733 | 168.851 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 2,740.62 | 2,289.223 | 1,074.241 | 481.337 | 162.391 | 77.88 | 48.185 | 31.347 | 29.103 |
| Goodwill
| 0 | 0 | 0 | 15.414 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 690.907 | 478.814 | 457.995 | 111.477 | 14.135 | 14.615 | 9.825 | 9.993 | 10.428 |
| Goodwill and Intangible Assets
| 690.907 | 478.814 | 457.995 | 126.891 | 14.135 | 14.615 | 9.825 | 9.993 | 10.428 |
| Long Term Investments
| -157.313 | 52.35 | -1,125.088 | -142.614 | 5.082 | 4.486 | 28.885 | 28.707 | 28.619 |
| Tax Assets
| 268.466 | 218.256 | 193.234 | 69.683 | 45.456 | 4.774 | 4.107 | 2.51 | 3.456 |
| Other Non-Current Assets
| 573.136 | 61.05 | 1,355.876 | 315.25 | 26.82 | 0.069 | 2.927 | 7.029 | 0.542 |
| Total Non-Current Assets
| 4,115.816 | 3,099.694 | 1,956.258 | 850.547 | 253.884 | 101.824 | 93.929 | 79.585 | 72.147 |
| Total Assets
| 8,094.58 | 8,995.951 | 10,703.739 | 8,976.971 | 3,573.223 | 361.511 | 337.648 | 259.318 | 240.998 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 515.489 | 578.497 | 1,580.069 | 1,173.678 | 371.974 | 49.152 | 48.603 | 47.016 | 39.768 |
| Short Term Debt
| 116.779 | 248.521 | 3.551 | 5.837 | 2.38 | 20.435 | 50 | 56 | 76 |
| Tax Payables
| 14.895 | 3.772 | 86.478 | 655.253 | 350.49 | 3.334 | 9.664 | 3.253 | 7.995 |
| Deferred Revenue
| 0 | 0 | 339.139 | 877.237 | 325.697 | 16.906 | 9.664 | 9.733 | 18.428 |
| Other Current Liabilities
| 556.638 | 254.997 | 269.244 | -653.489 | 62.47 | 1.689 | 3.331 | 0.502 | -5.108 |
| Total Current Liabilities
| 1,203.802 | 1,085.787 | 2,278.481 | 2,058.515 | 1,113.01 | 91.517 | 121.262 | 116.503 | 137.083 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 47.167 | 343.955 | 78.645 | 12.652 | 5.676 | 6.568 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 26.985 | 0.286 | 14.168 | 14.815 | 8.8 | 9.3 | 8.356 | 4.698 | 5.198 |
| Deferred Tax Liabilities Non-Current
| 0.233 | 0.036 | 2.765 | 0 | 0 | -6.568 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 24.962 | 16.158 | 6.686 | 17.015 | -5.676 | -3.699 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 99.346 | 360.436 | 102.265 | 29.667 | 8.8 | 15.868 | 8.356 | 4.698 | 5.198 |
| Total Liabilities
| 1,303.147 | 1,446.223 | 2,380.745 | 2,088.182 | 1,121.81 | 107.385 | 129.618 | 121.201 | 142.281 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 201.6 | 201.6 | 168 | 120 | 120 | 90 | 90 | 90 | 86.528 |
| Retained Earnings
| 6,183.651 | 6,712.674 | 7,446.257 | 6,140.684 | 1,724.593 | 114.872 | 72.346 | 13.672 | -12.413 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 112.666 | 50.577 | 55.536 | 21.761 | 38.688 | 29.817 | 24.603 |
| Other Total Stockholders Equity
| 259.84 | 521.798 | 548.589 | 545.913 | 609.31 | 25.095 | 37.878 | 29.817 | 24.603 |
| Total Shareholders Equity
| 6,645.091 | 7,436.071 | 8,162.846 | 6,857.174 | 2,446.043 | 251.728 | 201.034 | 133.489 | 98.717 |
| Total Equity
| 6,791.433 | 7,549.728 | 8,322.994 | 6,888.789 | 2,451.413 | 254.127 | 208.03 | 138.117 | 98.717 |
| Total Liabilities & Shareholders Equity
| 8,094.58 | 8,995.951 | 10,703.739 | 8,976.971 | 3,573.223 | 361.511 | 337.648 | 259.318 | 240.998 |